Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 918 across all filing types
Latest filing 2019-09-30 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings Classification · 100% confidence The document contains only references to omitted pictures and no textual content or financial data. The length is very short (325 characters) and there is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2019-09-30 English
Sub.: Proceeding of 31st Annual General Meeting (AGM) dated 30.09.2019
Regulatory Filings
2019-09-30 English
Outcome of Board Meeting
Regulatory Filings Classification · 100% confidence The document text is extremely short (175 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any regulatory information. Given the lack of content, this cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or empty filings.
2019-09-20 English
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. 20th September, 2019 has considered ....
Regulatory Filings
2019-09-20 English
Board Meeting — Other business matters
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 171 characters, which is extremely short and contains no report or announcement details. Given the lack of content, this cannot be classified as a full report or detailed announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive text.
2019-09-17 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/09/2019 ,inter alia, to consider and approve debt settlement plan, opportunity ....
Regulatory Filings
2019-09-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.